Control of cell differentiation during mouse embryogenesis and stem cell development
The research will provide insights into how progenitor cells for embryonic tissues may be specified and determine the conditions that promote differentiation into germ layer derivatives. The outcome will inform us on the molecular and signalling activities that control the first step of differentiation of multi-potent embryonic cells and stem cells to functionally competent cells.
The knowledge of how to maintain, expand and differentiate stem cells is essential for the realization of clinical cell-based therapy for the replacement and repair of diseased tissues. Cells of the early embryo are capable of generating many cell types, hence are regarded as pluripotent cells. As the embryo develops, there is a progressive restriction of the ability of the cells to do so. Cells in more advanced embryos will give rise to an increasingly limited set of cell types. We are documenting the genome-wide transcriptome (expression profiles) of the cell population at all definable positions in the embryo, which will enable the tracking of the essential activity of the gene regulatory network and signalling pathways driving cell fate choices and lineage progression during gastrulation. The network and pathway function will be verified by tracking lineage differentiation in genetically modified embryos.
Recently, stem cells have been derived from mouse embryos at the post-implantation stage. These epiblast stem cells differ from the conventional embryonic stem cells, regarding the culture conditions for maintenance and differentiation, suggesting that they are a different type of stem cell that are already predisposed for more specialized differentiation. This project will examine if these stem cells may be induced to differentiate more efficiently into specific types of embryonic tissue by recapitulating the genetic and signalling activity that regulate cell differentiation in the embryo. We will translate the knowledge gleaned from the study of mouse epiblast stem cells to the generation of synthetic cells, from human induced pluripotent stem cells, that possess unique attributes for therapeutic application.
Opportunity available for both Honours and PhD students
Methodologies: genome analysis (ChIP-nexus, RNA-seq, microfluidic qPCR and single-cell transcriptome), bioinformatics, cell and tissue culture, cell and molecular biological analyses of protein/gene expression, genome editing (CRISPR-Cas9) of cells and embryos, embryological analysis.
Eligibility: Honours entry: GPA on track for Hons I / IIA classification
PhD entry: Hons I classification, lab-based research experience is preferable.
The Children’s Medical Research Institute (CMRI) is an award-winning state-of-the-art medical research facility, with over 100 full-time scientists dedicated to researching the genes and proteins important for health and human development. The CMRI is supported in part by its key fundraiser Jeans for Genes®. Our scientists are internationally recognised research leaders and foster excellence in postgraduate training. CMRI graduates are highly sought after nationally and internationally.
CMRI is located at Westmead, a major hub for research and medicine in NSW, and is affiliated with the University of Sydney. Easy to access by public transport.
We are looking for top quality students who can prove a dedicated interest and enthusiasm for scientific research.
Candidates may apply for a CMRI PhD scholarship, which exceeds the Australian Postgraduate Awards and NHMRC scholarships in value. Visit the CMRI website for more details.
Want to find out more?
The opportunity ID for this research opportunity is: 128
Other opportunities with Professor Patrick Tam
- Head Development: Intersection of transcriptional and signalling activities
- Gene function in gut endoderm development
Other opportunities with Dr David Loebel